PLoS ONE · 2016 · 57 citations · 14 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryAntibacterial AgentsAntibacterial PharmacologyAntibacterial ResistanceEnzyme InhibitionMinimum Inhibitory Concentration TestingMycobacterial DiseaseMycobacterium Tuberculosis InfectionNovel Antibacterial AgentsNovel Antibacterial Drug DiscoveryThiazole ChemistryThiazole SynthesisTuberculosis Drug Development
The 2-aminothiazole series has anti-bacterial activity against the important global pathogen Mycobacterium tuberculosis. We explored the nature of the activity by designing and synthesizing a large number of analogs and testing these for activity against M. tuberculosis, as well as eukaryotic cells. We determined that the C-2 position of the thiazole can accommodate a range of lipophilic substitutions, while both the C-4 position and the thiazole core are sensitive to change. The series has good activity against M. tuberculosis growth with sub-micromolar minimum inhibitory concentrations being achieved. A representative analog was selective for mycobacterial species over other bacteria and was rapidly bactericidal against replicating M. tuberculosis. The mode of action does not appear to involve iron chelation. We conclude that this series has potential for further development as novel anti-tubercular agents.
14
Breeding latitude drives individual schedules in a trans-hemispheric migrant bird
Jesse R. Conklin, Phil F. Battley, Murray A. Potter et al. · Nature Communications · 2010 · 590 citations · Full text
Life Sciences, Ecology, Zoology +11
Jagabandhu Das, Ping Chen, Derek Norris et al. · Journal of Medicinal Chemistry · 2006 · 400 citations · Full text
Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against Tuberculosis
Lluís Ballell, Robert H. Bates, Rob J. Young et al. · ChemMedChem · 2013 · 310 citations · Full text
Kévin Pethe, Patrícia Carvalho de Sequeira, Sanjay Agarwalla et al. · Nature Communications · 2010 · 308 citations · Full text